ClearanceBrief
510(k) K980716 ยท LTJ Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

ADVANTAGE CHEMILUMINESCENCE PROSTATE SPECIFIC ANTIGEN (PSA) IMMUNOASSAY

ApplicantNichols Institute Diagnostics, San Juan Capistrano CA, US
DecisionSubstantially Equivalent, Apr 3, 1998
ReceivedJan 7, 1998
TypeTraditional
FDA recordOpen on fda.gov

Recalls that name K980716

No recall in the FDA data names this 510(k).

Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.